IP6K2 Human

Inositol Hexakisphosphate Kinase 2 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biochemical Functions and Gene Characteristics

IP6K2 is a 58-kDa protein with kinase activity specific to inositol phosphates. Key features include:

PropertyDetail
Gene LocusChromosome 3p21.31
Enzymatic ActivityConverts InsP6 to InsP7/PP-InsP5 and InsP5 to PP-InsP4
IsoformsMultiple transcript variants due to alternative splicing
InteractomeBinds creatine kinase-B (CK-B), GSK3, and components of the Hedgehog (Hh) pathway

IP6K2’s enzymatic products, such as InsP7, modulate cellular phosphate homeostasis and energy dynamics. Inositol pyrophosphates (IP7/PP-InsP4) generated by IP6K2 act as signaling molecules, inhibiting pro-growth pathways like PI3K/Akt/mTOR while promoting apoptosis in specific contexts .

Cellular Roles in Energy Metabolism and Neuroprotection

IP6K2 is essential for maintaining mitochondrial function and ATP production, particularly in neurons.

Energy Homeostasis in the Brain

  • CK-B Interaction: IP6K2 physically binds CK-B, a key enzyme in phosphocreatine (PCr)/ATP shuttling. Deletion of IP6K2 in mice reduces CK-B expression, leading to:

    • ↓ ATP and PCr levels in cerebellum .

    • ↑ Oxidative stress and mitochondrial dysfunction (e.g., impaired complex III activity) .

    • Rescue of ATP levels via N-acetylcysteine (NAC) or PCr supplementation mitigates neuronal death .

ParameterIP6K2-WTIP6K2-KO
ATP levelsNormal↓ 40–50%
PCr levelsNormal↓ 30–40%
ROS levelsLow↑ 2–3×
Cytochrome c1 (CIII)Normal↓ 50%

Data derived from PNAS studies .

Neuronal Morphogenesis

IP6K2-deficient neurons exhibit reduced dendritic branching, a phenotype reversible by ATP restoration. This underscores IP6K2’s role in neurodevelopment and synaptic plasticity .

Signaling Pathway Regulation

IP6K2 modulates key signaling cascades:

Hedgehog (Hh) Signaling

IP6K2 acts as a positive effector downstream of Smoothened (Smo) and upstream of Gli transcription factors. In zebrafish and mammalian models:

  • IP6K2 depletion inhibits Hh target gene expression (e.g., ptch2, gli1) .

  • Overexpression enhances Hh pathway activation, rescuing phenotypes caused by cyclopamine (a Smo inhibitor) .

Akt/GSK3 Pathway

IP6K2 binds GSK3, preventing its phosphorylation by Akt. This enhances GSK3 activity, suppressing pro-survival signals in cancer cells .

Clinical Relevance and Disease Associations

IP6K2’s dual roles in apoptosis and energy metabolism position it as a therapeutic target in cancer and neurodegeneration.

Cancer Prognosis

  • Breast Cancer: High IP6K2 expression correlates with ER positivity and improved survival in systemically untreated patients. This may reflect its inhibition of PI3K/Akt/mTOR signaling .

  • Ovarian Cancer: IP6K2 enhances interferon-β-induced apoptosis, suggesting a tumor-suppressive role .

Cancer TypeIP6K2 ExpressionClinical Outcome
BreastHighFavorable prognosis
OvarianVariableApoptosis induction

Neurological Disorders

IP6K2-KO mice exhibit mitochondrial complex III deficiency, a phenotype linked to Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease .

Key Studies

  1. IP6K2 and CK-B Interaction:

    • Model: IP6K2-KO mice.

    • Outcome: Impaired mitochondrial function and neurodegeneration.

    • Rescue: ATP restoration via PCr or NAC .

  2. Hh Pathway Modulation:

    • Model: Zebrafish and mammalian cells.

    • Outcome: IP6K2 depletion inhibits Hh signaling; overexpression enhances Gli activity .

  3. Phosphate Homeostasis:

    • Model: IP6K1/2 double-knockout (DKO) HCT116 cells.

    • Outcome: Loss of inositol pyrophosphates disrupts phosphate export and metabolism .

Product Specs

Introduction
Inositol Hexakisphosphate Kinase 2 (IP6K2) is an enzyme within the inositol IPK family that catalyzes the conversion of inositol hexakisphosphate to diphosphoinositol pentakisphosphate. Additionally, IP6K2 facilitates the conversion of 1, 3, 4, 5, 6-pentakisphosphate (InsP5) to PP-InsP4. This protein-coding gene plays a role in suppressing tumor growth and influencing the apoptotic effects of IFN-beta in various ovarian cancers.
Description
Recombinant human IP6K2, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 446 amino acids (1-426a.a) with a molecular weight of 51.3 kDa. This protein is fused to a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Colorless, sterile-filtered solution.
Formulation
The IP6K2 solution is provided at a concentration of 0.5 mg/ml in Tris-HCl buffer (pH 8.0) containing 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 85% as determined by SDS-PAGE analysis.
Synonyms
Inositol hexakisphosphate kinase 2 isoform a, IHPK2, PIUS, InsP6 kinase 2, P(i)-uptake stimulator, PiUS, IP6K2, TCCCIA00113.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MSPAFRAMDV EPRAKGVLLE PFVHQVGGHS CVLRFNETTL CKPLVPREHQ FYETLPAEMR KFTPQYKGVV SVRFEEDEDR NLCLIAYPLK GDHGIVDIVD NSDCEPKSKL LRWTTNKKHH VLETEKTPKD WVRQHRKEEK MKSHKLEEEF EWLKKSEVLY YTVEKKGNIS SQLKHYNPWS MKCHQQQLQR MKENAKHRNQ YKFILLENLT SRYEVPCVLD LKMGTRQHGD DASEEKAANQ IRKCQQSTSA VIGVRVCGMQ VYQAGSGQLM FMNKYHGRKL SVQGFKEALF QFFHNGRYLR RELLGPVLKK LTELKAVLER QESYRFYSSS LLVIYDGKER PEVVLDSDAE DLEDLSEESA DESAGAYAYK PIGASSVDVR MIDFAHTTCR LYGEDTVVHE GQDAGYIFGL QSLIDIVTEI SEESGE.

Product Science Overview

Function and Mechanism

IP6K2 is primarily responsible for the conversion of inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5) . This conversion is significant because InsP7 is involved in various cellular processes, including energy metabolism, apoptosis, and DNA repair . Additionally, IP6K2 can convert 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4 .

Biological Importance

The activity of IP6K2 is linked to several critical cellular functions:

  • Apoptosis: IP6K2 has been shown to affect the growth suppressive and apoptotic activities of interferon-beta in some ovarian cancers .
  • Energy Metabolism: By regulating the levels of inositol phosphates, IP6K2 plays a role in cellular energy homeostasis .
  • DNA Repair: InsP7, a product of IP6K2 activity, is involved in the DNA repair process, highlighting its importance in maintaining genomic stability .
Recombinant IP6K2

Recombinant human IP6K2 is produced using various expression systems, such as Escherichia coli . The recombinant protein is often tagged with a His tag at the N-terminus to facilitate purification and detection . The recombinant form retains the functional properties of the native protein, making it useful for research and therapeutic applications .

Applications in Research

Recombinant IP6K2 is widely used in biochemical and cellular studies to understand its role in inositol phosphate metabolism and its impact on cellular functions. It is also utilized in drug discovery and development, particularly in the context of cancer research, due to its involvement in apoptosis and growth suppression .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.